股票行情快报：祥生医疗（688358）11月19日主力资金净卖出55.91万元

Core Viewpoint - Xiangsheng Medical (688358) experienced a decline in stock price, closing at 32.84 yuan on November 19, 2025, down 2.73% with a trading volume of 8261 lots and a turnover of 27.32 million yuan [1] Financial Performance - For the first three quarters of 2025, Xiangsheng Medical reported a main business revenue of 343 million yuan, a year-on-year decrease of 5.27% [2] - The net profit attributable to shareholders was 93.92 million yuan, down 4.56% year-on-year, while the net profit after deducting non-recurring gains and losses was 86.97 million yuan, a decrease of 2.69% [2] - In Q3 2025, the company achieved a single-quarter main business revenue of 107 million yuan, down 6.68% year-on-year, but the single-quarter net profit attributable to shareholders increased by 41.95% to 24.22 million yuan [2] Market Position - Xiangsheng Medical's total market capitalization is 3.682 billion yuan, with a net asset value of 1.4 billion yuan, ranking 93rd in the medical device industry [2] - The company has a price-to-earnings ratio of 29.4 and a price-to-book ratio of 2.63, both of which are favorable compared to the industry averages [2] Investment Sentiment - In the last 90 days, four institutions have given buy ratings for Xiangsheng Medical, indicating positive sentiment among analysts [3]